NTV Asset Management LLC Makes New $661,000 Investment in VanEck Pharmaceutical ETF $PPH

NTV Asset Management LLC bought a new stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) during the 3rd quarter, HoldingsChannel reports. The firm bought 6,033 shares of the company’s stock, valued at approximately $661,000.

A number of other institutional investors have also bought and sold shares of the company. Royal Bank of Canada boosted its position in VanEck Pharmaceutical ETF by 846.9% during the first quarter. Royal Bank of Canada now owns 361,001 shares of the company’s stock valued at $37,501,000 after acquiring an additional 322,878 shares during the last quarter. Bank of America Corp DE grew its holdings in VanEck Pharmaceutical ETF by 139.3% during the 1st quarter. Bank of America Corp DE now owns 143,609 shares of the company’s stock worth $14,918,000 after acquiring an additional 83,598 shares during the period. Fluent Financial LLC bought a new position in shares of VanEck Pharmaceutical ETF in the 2nd quarter worth about $4,264,000. Avior Wealth Management LLC bought a new position in shares of VanEck Pharmaceutical ETF in the 3rd quarter worth about $1,685,000. Finally, ARQ Wealth Advisors LLC bought a new position in shares of VanEck Pharmaceutical ETF in the 1st quarter worth about $938,000.

VanEck Pharmaceutical ETF Price Performance

Shares of NASDAQ:PPH opened at $114.93 on Monday. The company has a market capitalization of $1.07 billion, a price-to-earnings ratio of 20.21 and a beta of 0.45. The business’s 50-day moving average is $112.41 and its 200-day moving average is $108.22. VanEck Pharmaceutical ETF has a 1 year low of $90.74 and a 1 year high of $118.03.

VanEck Pharmaceutical ETF Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, October 6th. Investors of record on Thursday, October 1st were paid a dividend of $0.36 per share. This is a decrease from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.6248. This represents a $1.44 annualized dividend and a yield of 1.3%. The ex-dividend date of this dividend was Thursday, October 1st.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.